| Literature DB >> 30144453 |
Elżbieta Żmudzka1, Kinga Sałaciak1, Jacek Sapa1, Karolina Pytka2.
Abstract
Serotonin regulates many physiological processes including sleep, appetite, and mood. Thus, serotonergic system is an important target in the treatment of psychiatric disorders, such as major depression and anxiety. This natural neurotransmitter interacts with 7 families of its receptors (5-HT1-7), which cause a variety of pharmacological effects. Using genetically modified animals and selective or preferential agonists and antagonist, numerous studies demonstrated the involvement of almost all serotonin receptor subtypes in antidepressant- or anxiolytic-like effects. In this review, based on animal studies, we discuss the possible involvement of serotonin receptor subtypes in depression and anxiety.Entities:
Keywords: Animal studies; Antidepressant-like; Anxiolytic-like; Serotonin; Serotonin receptors
Mesh:
Substances:
Year: 2018 PMID: 30144453 DOI: 10.1016/j.lfs.2018.08.050
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037